GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Advanced Enzyme Technologies Ltd

Advanced Enzyme Technologies Buys Back 61,900 Shares on Oct 26

BUYBACK ▲ Positive Development LOW RISK
📅 Filed on BSE: 26 Oct 2026, 06:12 PM IST  ·  BSE ID: 1be90b4d-2950-4369-9364-c6ae97dfc122
View Original BSE Filing (PDF)
💡
In Simple Terms
The company bought back its own shares from the stock market on October 26, 2026, as part of an ongoing program.
🤖 AI Summary
  • Advanced Enzyme Technologies bought back 61,900 equity shares on October 26, 2026.
  • The average acquisition price for these shares was ₹251.2710 per share.
  • The buyback was conducted through Emkay Global Financial Services Limited on the BSE.
  • Cumulative shares bought back have reached 22,62,753 as of October 26, 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Number of Equity Shares bought back on October 26, 2026
61,900
Average Price of acquisition on October 26, 2026
251.2710
Cumulative Equity Shares bought as on October 26, 2026
22,62,753
🏢 How This Affects the Company
💰
Financial Impact
The buyback reduces the number of outstanding shares, potentially increasing earnings per share for remaining shareholders.
👥 What This Means For Shareholders
✅
Action Required
No action is required by shareholders regarding this daily buyback report.
👤
Who Is Affected
Shareholders who held shares on October 26, 2026, are indirectly affected by the reduction in outstanding shares.
🔍
Management Signal
The continued buyback signals management's intent to return capital to shareholders and potentially support the stock price.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Next daily buyback report for October 27, 2026.
Company's overall buyback progress against authorized limit.
Future quarterly shareholding pattern disclosures.
LOW RISK Routine corporate action with transparent reporting; no new risks identified.
💡 Investor Takeaway
Advanced Enzyme Technologies bought back 61,900 shares on October 26, 2026, at ₹251.2710 average price. Cumulative buyback now stands at 22,62,753 shares.
⚖️ Strengths & Concerns

✅ Positives

  • Company continues systematic share buyback activity, demonstrating commitment to shareholder returns.
  • 61,900 shares repurchased on October 26, 2026, contributing to ongoing buyback program.
📅 Company Track Record
Advanced Enzyme Technologies has actively engaged in share buybacks, as evidenced by previous filings on October 27, 21, and 16, 2026, reflecting a consistent capital return strategy.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
How many shares did Advanced Enzyme Technologies buy back on October 26, 2026?
Advanced Enzyme Technologies bought back 61,900 equity shares on October 26, 2026.
What was the average price of shares bought back by Advanced Enzyme on October 26, 2026?
The average acquisition price for shares bought back on October 26, 2026, was ₹251.2710.
What is the total number of shares bought back by Advanced Enzyme as of October 26, 2026?
As of October 26, 2026, a total of 22,62,753 equity shares have been bought back.
Which broker facilitated the share buyback on October 26, 2026, for Advanced Enzyme?
Emkay Global Financial Services Limited facilitated the buyback of 61,900 shares on October 26, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.